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Abstract
Background: Extracranial traumatic cerebrovascular injury (TCVI) is present in 1-3% of all blunt force trauma
patients. Although options for the management of patients with these lesions include anticoagulation, antiplatelet
agents, and endovascular treatment, the optimal management strategy for patients with these lesions is not yet
established.
Objective: Multidisciplinary survey of clinicians about current management of TCVI.
Methods: A six-item multiple-choice survey was sent by electronic mail to a total of 11,784 neurosurgeons, trauma
surgeons, stroke neurologists, and interventional radiologists. The survey included questions about their choice of
imaging, medical management, and the use of endovascular techniques. Survey responses were analyzed
according to stated specialty.
Results: Seven hundred eighty-five (6.7%) responses were received. Overall, a total of 325 (42.8%) respondents
favored anticoagulation (heparin and/or warfarin), 247 (32.5%) favored antiplatelet drugs, 130 (17.1%) preferred
both anticoagulation and antiplatelet drugs, and 57 (7.5%) preferred stenting and/or embolization. Anticoagulation
was the most commonly preferred treatment among vascular surgeons (56.9%), neurologists (50.2%) and
neurosurgeons (40.7%), whereas antiplatelet agents were the most common preferred treatment among trauma
surgeons (41.5%). Overall, 158 (20.7%) of respondents recommended treatment of asymptomatic dissections and
traumatic aneurysms, 211 (27.7%) did not recommend it, and 39.4% recommended endovascular treatment only if
there is worsening of the lesion on follow-up imaging.
Conclusions: These data demonstrate the wide variability of physicians’ management of traumatic cerebrovascular
injury, both on an individual basis, and between specialties. These findings underscore the need for multicenter,
randomized trials in this field.
Background
Blunt extracranial traumatic cerebrovascular injury
(TCVI) is found in some 1-3% of all blunt force trauma
patients [1-15]. Estimates of overall neurological mor-
bidity associated with TCVI range as high as 31%
[2,14,16]. Ischemic stroke appears to be the greatest
source of neurological morbidity in this setting. A recent
report of 147 patients with TCVI found an ischemic
stroke rate of 12% attributable to carotid injuries and
8% due to vertebral artery injuries [2]. Although antith-
rombotic therapy to prevent ischemic stroke has been
widely reported, several different options exist, including
anticoagulation[2,7,9,17-19] and antiplatelet therapy
[2,16,20-22]. Furthermore, the use of endovascular tech-
niques in patients with TCVI appears to be gaining in
popularity [23-26].
The optimal management strategy for patients with
TCVI has not yet been established. No randomized trials
in the management of patients with TCVI have yet been
published. The issue is complicated by the complex
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of cerebrovascular injuries as well as the presence of
polytrauma. Furthermore, cerebrovascular injury in
trauma patients frequently involves the participation of
numerous specialists, such as neurosurgeons, trauma
surgeons, stroke neurologists, and interventional neuror-
adiologists. Differing disciplines may have different per-
spectives and practices in the management of patients
with TCVI.
The purpose of the current investigation was to assess
the current management of patients with TCVI across
the United States and also across the various medical
specialties involved with the management of patients
with TCVI.
Methods
A six-item multiple-choice survey was sent by electronic
mail to 11,784 members of the American Association
for the Surgery of Trauma, the American Association of
Neurological Surgeons, the American Heart Association
Stroke Council, and the Society for Clinical Vascular
Surgery. Email addresses were obtained from published
membership lists. The authors attempted to exclude
email addresses that overlapped between organizations.
This project was approved by the Institutional Review
Board.
Results were collected on a commercial survey website
(http://www.surveymonkey.com). Only a single mass
emailing was completed, and the survey was closed after
one month. No follow-up emails or repeat email solici-
tations were used. All responses were kept completely
confidential.
Standard two-sided chi-square tests were used to test
for significant associations between specialty and survey
responses. Because some expected cell counts were less
than 5, results were confirmed using Monte-Carlo
approximations of Fisher’s exact test with one million
repetitions. Testing was done using R version 2.10.1.
Results
A total of 785 responses were received, representing an
overall response rate of 6.7%. Members of the American
Association for the Surgery of Trauma had the highest
response rate, at 15.7% (Table 1). Several emails were
received from recipients of the survey, explaining that
they were not clinicians, not physicians, or did not take
care of patients with TCVI.
Overall survey results
The total responses to the survey questions are listed in
Table 2. The largest number of respondents were neuro-
surgeons (342, 45.2%) and the next largest responding
specialty was neurology (205, 27.1%). Only 46 of the
respondents (6.0%) reported seeing no TCVI cases each
year; the most common frequency was 1-5 per year,
which was reported by 442 (57.4%) of the respondents.
A conservative estimate of the total number of TCVI
cases seen by the respondents can be estimated by mul-
tiplying number of respondents reporting each range of
cases per year by the lowest number in each range.
Thus, as a group, the respondents estimated that they
see at least 2,680 TCVI cases each year.
The most common preferred method of imaging was
computed tomographic angiography (CTA, 22.8%), fol-
lowed by MRI/MRA (22.8%) and catheter angiography
(15.0%). The most common preferred treatment was
anticoagulation (42.8%) and antiplatelet drugs (32.5%).
Regarding management of a patient with intraluminal
thrombus and no related symptoms, the most common
choice was heparin and/or warfarin (65.7%), followed by
antiplatelet drugs (22.9%) and thrombolytics (6.2%).
Some 20.7% of the respondents recommend treatment
of asymptomatic dissections and traumatic aneurysms
with endovascular techniques, while 2.7% would not and
51.6% would do so only if there were worsening of the
lesion on follow-up imaging.
Analysis by specialty
For each question there was a statistically significant
association between response and medical specialty (all
P < 0.00005 for both chi-square test and Fisher’s exact
test). The medical specialties with the greatest annual
number of TCVI cases seen per respondent were inter-
ventional radiologists, followed by trauma surgeons and
neurologists (Table 3). Regarding imaging, CTA was
favored by a majority of respondents in each specialty,
although 39.0% of neurologists preferred MRI/MRA
(Table 4). Some 26.7% of interventional radiologists and
21.8% of neurosurgeons preferred catheter angiography.
Anticoagulation was the most common preferred treat-
ment among neurosurgeons, vascular surgeons, and
neurologists, whereas antiplatelet agents were most
commonly favored among trauma surgeons and general
surgeons (Table 5). A minority of respondents in each
specialty, ranging from 3.0% to 10.7%, preferred stenting
and/or embolization. Responses to questions about
Table 1 Responses according to professional society
Number of survey
requests sent
Number of
responses
American Association of
Neurological Surgeons
5,481 335 (6.1%)
American Association for the
Surgery of Trauma
923 145 (15.7%)
American Heart Association
Stroke Council
4,638 263 (5.7%)
Society for Clinical Vascular
Surgery
742 42 (5.7%)
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For patients with an asymptomatic intraluminal throm-
bus, the majority of respondents in all specialties pre-
ferred heparin and/or warfarin; antiplatelet agents were
the next most commonly favored treatment, followed by
thrombolytics. Regarding asymptomatic dissections and
traumatic aneurysms, the most common opinion among
all specialties was that endovascular techniques should
either not be used or they should be reserved for lesions
that are found to worsen on follow-up imaging. How-
ever, neurosurgeons, trauma surgeons, and general sur-
geons were significantly more likely than vascular
surgeons, neurologists and interventional radiologists to
recommend endovascular treatment of asymptomatic
lesions.
Discussion
The overall response rate in this study, 6.7%, is lower
than the response rates reported in other published neu-
rosurgical and trauma email surveys, which have ranged
from 11.4% to 56% [27-31]. However, a significant num-
ber of the recipients of this email survey were either not
clinicians or are clinicians who do not see patients with
TCVI. The authors received several emails from recipi-
ents of the survey explaining this. For instance, many
members of the AANS are neurosurgeons who do not
see trauma patients, and a number of members of the
AHA Stroke Council are Ph.D.s or nurses who also do
not participate in the care of patients with traumatic
injury. Furthermore, the recipients of the survey who
did respond may account for a significant percentage of
the clinicians who actually do take care of patients with
TCVI in the United States. The lowest estimated total
number of TCVI cases per year seen by the respondents
is 2,680. The average annual number of blunt trauma
admissions from 2000 to 2004 in the United States, as
tabulated by the National Trauma Data Bank, was
162,306 [32]. Therefore, the lowest estimate of TCVI
cases seen annually by the survey respondents represent
approximately 1.7% of the total number of blunt trauma
admissions in the United States, which is within the
range of the overall incidence of TCVI (1-3%) among
blunt trauma patients [1-15]. Thus, despite the see-
mingly low survey response rate, the respondents of this
survey may represent a sizable fraction of the clinicians
managing TCVI in the United States.
This survey demonstrates considerable variability in all
aspects of the management of patients with TCVI, from
Table 3 Case volume by specialty
Question: What is the approximate number of traumatic carotid or vertebral artery dissections or other injuries that you see per year?
None 1 to 5 5 to 10 > 10
Neurosurgeon n = 342 28 (8.2%) 237 (69.5%) 35 (10.3%) 41 (12.0%)
Trauma surgeon n = 136 2 (1.5%) 58 (42.6%) 29 (21.3%) 47 (34.6%)
General surgeon n = 19 4 (21.1%) 6 (31.6%) 4 (21.1%) 5 (26.3%)
Vascular surgeon n = 52 4 (7.7%) 36 (69.2%) 9 (17.3%) 3 (5.8%)
Neurologist n = 204 6 (2.9%) 102 (50.0%) 61 (29.9%) 35 (17.2%)
Interventional radiologist n = 30 0 6 (20.0%) 8 (26.7%) 16 (53.3%)
Table 2 Overall responses to the questionnaire
1. What is your specialty?
￿ Trauma surgeon = 137 (18.1%)
￿ General surgeon = 19 (2.5%)
￿ Neurosurgeon = 342 (45.2%)
￿ Vascular surgeon = 52 (6.9%)
￿ Neurologist = 205 (27.1%)
￿ Interventional radiologist = 30 (4.0%)
2. What is the approximate number of traumatic carotid or vertebral
artery dissections or other injuries that you see per year?
￿ None = 46 (6.0%)
￿ 1-5 = 442 (57.4%)
￿ 5-10 = 144 (18.7%)
￿ > 10 = 138 (17.9%)
3. What is your preferred method of imaging?
￿ MRI/MRA = 175 (22.8%)
￿ CTA = 464 (60.5%)
￿ Doppler = 13 (1.7%)
￿ Catheter angiography = 115 (15.0%)
4. In most cases which treatment do you prefer?
￿ Anticoagulation (heparin and/or warfarin) = 325 (42.8%)
￿ Antiplatelet drugs = 247 (32.5%)
￿ Both anticoagulation and antiplatelet drugs = 130 (17.1%)
￿ Stent and/or embolization = 57 (7.5%)
5. How would you manage a patient with intraluminal thrombus and
no related neurological symptoms?
￿ Thrombolytics = 47 (6.2%)
￿ Heparin and/or warfarin = 500 (65.7%)
￿ Antiplatelet drugs = 174 (22.9%)
￿ None of the above = 40 (5.3%)
6. Should asymptomatic traumatic dissections and traumatic
aneurysms be treated with endovascular techniques, such as
stenting and/or embolization?
￿ Yes = 158 (20.7%)
￿ No = 211 (27.7%)
￿ Only if there is worsening of the lesion on follow-up imaging =
394 (51.6%)
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techniques. The most commonly preferred method of
imaging was CTA, which likely reflects the ubiquity of CT
scanning in the work-up of trauma patients, the wide-
spread use of CTA for screening of trauma patients who
are at risk of having a TCVI, and numerous published stu-
dies of CTA in this setting [14,33-37]. However, a signifi-
cant subset of respondents (22.8%) favored MRI/MRA.
This modality was most popular among neurologists, of
whom 39.0% favored MRI/MRA. This may reflect current
practice in the management of patients with spontaneous
cervical artery dissection as expressed in a recent survey of
members of the British Association of Stroke Physicians,
90% of whom indicated MRI/MRA as their preferred
method of imaging in that setting. Overall, only 15% in the
present survey preferred catheter angiography. Recently
published guidelines for the management of blunt cerebro-
vascular injury by the Eastern Association for the Surgery
of Trauma concluded that four-vessel cerebral angiogra-
phy remains the gold standard for diagnosis, that duplex
ultrasonography is not adequate for screening, and that
multislice (eight or greater) CTA may be considered as a
screening modality in place of catheter angiography[38]
The authors of the guidelines also recommended that fol-
low-up catheter angiography be done for grades I to III
injuries. Grade I injuries include intimal irregularities with
< 25% narrowing; grade II injuries consist of dissections or
intramural hematomas with > 25% narrowing; and grade
III injuries are dissecting aneurysms [39].
With respect to management, the most commonly
preferred treatments overall were anticoagulation
(42.8%) and antiplatelet agents (32.5%). These results are
virtually identical to the findings of the British survey
about spontaneous cervical artery dissection; those
respondents were also divided between preferring antic-
oagulation (50%) or antiplatelet agents (30%) [40]. A
number of studies of TCVI have found an association
between antithrombotic therapy and lower ischemic
stroke rates [2,7,9,14,17-19,41], although a cause and
effect relationship has not been demonstrated in a con-
trolled study. Treatment of patients with TCVI with
anticoagulation using heparin and warfarin has been
more widely reported than treatment with antiplatelet
agents [2,7,9,17-19]. However, systemic anticoagulation
is associated with bleeding complication rates up to 16%
[7,14,17,42] and up to 36% of patients with TCVI are
not candidates for systemic anticoagulation due to coex-
istent injuries [2,20]. Antiplatelet therapy (single agent
treatment with aspirin is the most commonly reported
regimen) may have a lower risk of complications and
several retrospective studies have indicated that antipla-
telet therapy is equal to or superior to anticoagulation
in terms of neurological outcomes [2,16,20-22].
The Eastern Association for the Surgery of Trauma
blunt TCVI guidelines made treatment recommenda-
tions according to the type of lesion [38]. Barring con-
traindications, antithrombotic medications such as
aspirin or heparin were recommended for grade I and II
TCVIs. The authors of the guidelines concluded that
either heparin or antiplatelet therapy may be used with
seemingly equivalent results. Although they stated that
they could not make any recommendations about how
long antithrombotic therapy should be administered for
patients receiving anticoagulation, the authors
Table 4 Preferred imaging by specialty
Question: What is your preferred method of imaging?
MRI/MRA CTA Doppler Catheter angiography
Neurosurgeon n = 339 72 (21.1%) 189 (55.8%) 4 (1.2%) 74 (21.8%)
Trauma surgeon n = 137 6 (4.4%) 127 (92.7%) 0 4 (2.9%)
General surgeon n = 19 6 (31.6%) 12 (63.2%) 0 1 (5.3%)
Vascular surgeon n = 52 7 (13.5%) 40 (76.9%) 3 (5.8%) 2 (3.8%)
Neurologist n = 205 80 (39.0%) 87 (42.4%) 6 (2.9%) 32 (15.6%)
Interventional radiologist n = 30 2 (6.7%) 20 (66.7%) 0 8 (26.7%)
Table 5 Preferred treatment by specialty
Question: In most cases which treatment do you prefer?
Anticoagulation Antiplatelet drugs Both Stent/embolization
Neurosurgeon n = 337 137 (40.7%) 105 (31.2%) 59 (17.5%) 36 (10.7%)
Trauma surgeon n = 135 39 (28.9%) 56 (41.5%) 34 (25.2%) 6 (4.4%)
General surgeon n = 19 7 (36.8%) 8 (42.1%) 2 (10.5%) 2 (10.5%)
Vascular surgeon n = 51 29 (56.9%) 8 (15.7%) 9 (17.6%) 5 (9.8%)
Neurologist n = 202 101 (50.0%) 71 (35.1%) 24 (11.9%) 6 (3.0%)
Interventional radiologist n = 30 13 (43.3%) 13 (43.3%) 2 (6.7%) 2 (6.7%)
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months. They recommended consideration of surgery or
endovascular treatment of grade III lesions (dissecting
aneurysms), and surgical or endovascular repair of caro-
tid lesions associated with an early neurological deficit.
Regarding the management of asymptomatic lesions,
the majority of respondents overall (65.7%) would man-
age a patient with a clinically silent intraluminal throm-
bus with heparin and/or warfarin, whereas 22.9% would
use antiplatelet drugs and 6.2% would use thrombolytics.
Additionally, 20.7% would use stenting and/or emboliza-
tion to treat asymptomatic dissections and traumatic
aneurysms, while a slim majority (51.6%) would use
these techniques only if there were worsening of the
lesion on follow-up imaging. The question of the man-
agement of asymptomatic TCVI lesions is important
because of the widespread use of CTA screening proto-
cols. Screening protocols call for CTA imaging of blunt
trauma patients with risk factors for TCVI, such as cer-
vical spine injuries and skull base fractures. Screening of
asymptomatic patients is somewhat controversial [38],
as some data indicates that a significant number of
ischemic strokes due to TCVI occur prior to diagnosis
[2,43], and that asymptomatic TCVI lesions may carry a
relatively low risk of subsequent stroke, particularly
when some variety of antithrombotic therapy is used.
Thus, the situation with extracranial TCVI may be ana-
logous to extracranial atherosclerotic disease, in that
asymptomatic lesions carry a much more benign prog-
nosis than symptomatic lesions. Differentiation in out-
comes and management options between symptomatic
and asymptomatic TCVI lesions is fertile ground for
future investigation.
Endovascular treatment with stenting and/or emboli-
zation was the preferred method of treatment for 7.5%
of the respondents overall, and was most popular
among neurosurgeons (10.7%), compared to other spe-
cialists. The use of endovascular techniques in the man-
agement of patients with TCVI has been reported with
increasing frequency in recent years [16,23-26,44-49].
However, compared to the other issues surrounding
TCVI, the actual clinical benefit of endovascular treat-
ment remains the least well defined, underscoring the
need for prospective clinical investigation.
Responses to the survey questions varied considerably
by specialty. Differences in opinion between specialties
were significant for estimated case volume, preferred
imaging, preferred treatment, and the management of
asymptomatic lesions. These differences likely reflect
standards of training within each field, clinical perspec-
tives, experience, and philosophies within individual dis-
ciplines. It is not surprising that trauma surgeons see a
large volume of TCVI cases and that CTA is their pre-
ferred method of imaging, since CT is currently widely
used for imaging of trauma patients. Similarly, the
observation that the majority (56.9%) of vascular sur-
geons prefer anticoagulation for treatment - more than
any other specialty - may parallel practice guidelines for
the treatment of other problems commonly encountered
by vascular surgeons, such as peripheral arterial disease
[50]. It is less clear why neurosurgeons, trauma sur-
geons, and general surgeons are more likely to use
endovascular techniques to treat clinically silent TCVI
lesions than vascular surgeons, neurologists, and inter-
ventional radiologists. The care of TCVI patients, parti-
cularly those with polytrauma, does typically involve the
Table 6 Management of asymptomatic lesions by specialty
Question: How would you manage a patient with intraluminal thrombus and no related neurological symptoms?
Thrombolytics Heparin and/or warfarin Antiplatelets None of the above
Neurosurgeon n = 339 35 (10.3%) 205 (60.5%) 85 (25.1%) 14 (4.1%)
Trauma surgeon n = 135 7 (5.2%) 82 (60.7%) 34 (25.2%) 12 (8.9%)
General surgeon n = 19 2 (10.5%) 12 (63.2%) 3 (15.8%) 2 (10.5%)
Vascular surgeon n = 52 2 (3.8%) 39 (75.0%) 4 (7.7%) 7 (13.5%)
Neurologist n = 202 1 (0.5%) 148 (73.3%) 46 (22.8%) 7 (3.5%)
Interventional radiologist n = 29 0 22 (75.9%) 6 (20.7%) 1 (3.4%)
Question: Should asymptomatic traumatic dissections and traumatic aneurysms be treated with endovascular techniques, such as
stenting and/or embolization?
Yes No Only if there is worsening on follow-up imaging
Neurosurgeon n = 339 85 (25.1%) 66 (19.5%) 188 (55.5%)
Trauma surgeon n = 134 37 (27.6%) 33 (24.6%) 64 (47.8%)
General surgeon n = 19 5 (26.3%) 7 (36.8%) 7 (36.8%)
Vascular surgeon n = 52 8 (15.4%) 20 (38.5%) 24 (46.2%)
Neurologist n = 202 25 (12.4%) 86 (42.6%) 91 (45.0%)
Interventional radiologist n = 30 4 (13.3%) 7 (23.3%) 19 (63.3%)
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variation found by this survey highlights the utility of
involving multiple specialties in future clinical trials of
TCVI, and to include multiple specialties in the formu-
lation of future practice guidelines.
Limitations of this study include the modest overall
response rate and the variability in the numbers of
respondents representing the different medical disci-
plines. However, as mentioned above, the respondents
to this survey may represent a significant proportion of
clinicians who actively participate in the management of
TCVI in the United States. Another limitation concerns
the restricted format of this survey. This single-page six-
question format, without a large number of answer
options for each question and without space to type out
comments, was intended to keep the email survey brief
to maximize recipient participation. In the view of some
of the recipients of this survey, however, the brevity of
the survey over-simplified the issues associated with
TCVI management. The survey was meant to focus on
the core questions without taxing the respondents’ time
and effort to an unreasonable degree.
Conclusions
The results of this survey show that there is poor agree-
ment on the management of patients with TCVI, from
the method of imaging to medical and endovascular
treatment and the handling of patients with asympto-
matic lesions. These differing views reflect the absence
of randomized trial data and well-defined treatment
algorithms. Practice differences between medical disci-
plines underscores the need for and the value of multi-
disciplinary clinical trials and guidelines.
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